Pathways Linking Reduced Sleep Duration and Quality to Obesity Risk
1 other identifier
interventional
23
1 country
1
Brief Summary
This study is designed to study the pathways through which short sleep duration or poor sleep quality can lead to an increased risk of developing diabetes and obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started Jan 2007
Longer than P75 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2007
CompletedFirst Submitted
Initial submission to the registry
June 3, 2009
CompletedFirst Posted
Study publicly available on registry
June 8, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedSeptember 5, 2013
September 1, 2013
5.5 years
June 3, 2009
September 4, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Disposition Index reflecting Diabetes Risk as a result of decreased sleep duration and/or quality.
3 months
Study Arms (3)
Baseline
EXPERIMENTALSubjects are tested under normal sleep conditions for carbohydrate metabolism and appetite regulation.
Sleep restriction
EXPERIMENTALSubjects are tested under sleep restriction for carbohydrate metabolism and appetite regulation.
Reduced sleep quality
EXPERIMENTALSubjects are tested under a poor sleep quality condition for carbohydrate metabolism and appetite regulation.
Interventions
Eligibility Criteria
You may qualify if:
- Normal weight
- Healthy
- Normal sleep times
You may not qualify if:
- Sleep disorders
- Overweight
- Diabetes
- Other health conditions
- Excessive caffeine and alcohol intake
- Smoking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Chicago
Chicago, Illinois, 60637, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Esra Tasali, MD
University of Chicago
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2009
First Posted
June 8, 2009
Study Start
January 1, 2007
Primary Completion
July 1, 2012
Study Completion
July 1, 2012
Last Updated
September 5, 2013
Record last verified: 2013-09